History

Kipa Pharmacal Ltd started its activities in 1981. Over the years the company has successfully gained a significant share of high quality products in Cyprus.

Since 2005, after the integration of Cyprus in the EU, KIPA changed its strategy and focused on generic pharmaceutical products. Our main licensor is KRKA/TAD, one of the leading generic companies worldwide.

In 2010 KIPA signed an agreement to market probiotic products from Probionov France and the following year we started co-operating with DanPharm Ltd from Israel.